Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Eurofarma Laboratorios S.A. clinical trials
The registry lists 65 studies whose lead sponsor is Eurofarma Laboratorios S.A. or one of 1 company grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Eurofarma Laboratorios S.A. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Eurofarma Laboratorios S.A..
Studies
Recruiting first, then most recently updated. Showing 50 of 65. Browse all 65 →
- Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)Not yet recruitingNCT07714616Phase 3
- Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO)Not yet recruitingNCT06546735Phase 3
- Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)Not yet recruitingNCT06234345Phase 3
- Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne VulgarisRecruitingNCT06905210Phase 3
- Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.Not yet recruitingNCT07529977Phase 3
- Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)Not yet recruitingNCT07303322Phase 3
- Evaluation of the EF192B Protection Versus No TreatmentNot yet recruitingNCT06752460Not applicable
- Treatment of Androgenetic Alopecia in Men for 24 WeeksCompletedNCT04721548Phase 3
- Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar ExtractionCompletedNCT05081102Phase 3
- Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)WithdrawnNCT07318350Phase 3
- Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar ExtractionCompletedNCT04972292Phase 3
- Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of MigraineCompletedNCT04384367Phase 3
- Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential HypertensionWithdrawnNCT06608472Phase 3
- Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold TreatmentCompletedNCT05118672Phase 3
- A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD TreatmentCompletedNCT04233190Phase 3
- Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in ChildrenCompletedNCT05214911Phase 3
- Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in BrazilWithdrawnNCT05735431Phase 3
- Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral NeuropathyWithdrawnNCT06715462Phase 3
- Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in BrazilWithdrawnNCT05637710Phase 3
- A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With OverweightWithdrawnNCT05209984Phase 3
- iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)WithdrawnNCT06560333Phase 3
- Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on MetforminWithdrawnNCT07057479Phase 3
- Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized ConditionsCompletedNCT06731062Not applicable
- Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial HypertensionCompletedNCT01191450Phase 3
- A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in AsthmaCompletedNCT01167010Phase 3
- Evaluation of Skin Irritancy and Sensitization of a Liquid BandageCompletedNCT05876546Not applicable
- Goserelin 10.8mg Injection in Treatment of Advanced Prostate CancerCompletedNCT03936218Phase 3
- Evaluation of the Protection of a Liquid BandageCompletedNCT05888311Not applicable
- The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal WomenCompletedNCT03835325Not applicable
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBICWithdrawnNCT01471925Phase 3
- A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal CancerCompletedNCT01249352Phase 2/3
- A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with AsthmaCompletedNCT01202097Phase 3
- Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic PainCompletedNCT01147289Phase 3
- Study Comparing Radiation Therapy and Chemotherapy With or Without NimotuzumabWithdrawnNCT01345084Phase 3
- A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with AsthmaCompletedNCT01001364Phase 3
- Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesityWithdrawnNCT05209997
- Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast CancerTerminatedNCT03936933Phase 3
- Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in BrazilWithdrawnNCT05683574Phase 3
- Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the KneeCompletedNCT00955552Phase 3
- Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct EdemaTerminatedNCT01210365Phase 3
- A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical StudyWithdrawnNCT03936192Phase 3
- UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.CompletedNCT05148377Phase 3
- Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic RhinitisWithdrawnNCT02972866Phase 3
- Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)CompletedNCT02830919Phase 3
- Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic RhinitisWithdrawnNCT02988778Phase 3
- Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic DermatitisCompletedNCT02945657Phase 2
Sponsor listed in the registry: Medimetriks Pharmaceuticals, Inc · First submitted before Medimetriks Pharmaceuticals, Inc became part of Eurofarma Laboratorios S.A.
- Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)CompletedNCT02689362Phase 2
- Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/EthyniestradiolWithdrawnNCT01557023Phase 3
- A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)CompletedNCT01372865Phase 3
- Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving ChemotherapyWithdrawnNCT02768714Phase 3